Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

4.1%

2 terminated/withdrawn out of 49 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

27%

13 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

16 recruiting

Enrollment Performance

Analytics

N/A
15(41.7%)
Phase 3
10(27.8%)
Phase 2
8(22.2%)
Phase 4
3(8.3%)
36Total
N/A(15)
Phase 3(10)
Phase 2(8)
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials
NCT07454941Enrolling By Invitation

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

Role: collaborator

NCT07083154Phase 3Recruiting

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Role: collaborator

NCT07278700Recruiting

The Fever Clinic Acute Respiratory Cohort

Role: collaborator

NCT07272499Phase 2Recruiting

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Role: collaborator

NCT03013010Phase 3Completed

PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy

Role: collaborator

NCT07256223Phase 2Not Yet Recruiting

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

Role: collaborator

NCT04966793Recruiting

Microbial Colonization Distribution and Adaptive Evolution of Lower Respiratory Tract in Bronchiectasis Patients.

Role: collaborator

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT07199296Phase 2Recruiting

Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment

Role: collaborator

NCT07169903Phase 3Not Yet Recruiting

Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT

Role: collaborator

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT07029464Not Yet Recruiting

Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis

Role: collaborator

NCT06882278Not Yet Recruiting

Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster Headache

Role: collaborator

NCT06874673Not ApplicableNot Yet Recruiting

Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis

Role: collaborator

NCT06322680Not ApplicableRecruiting

Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy

Role: collaborator

NCT06658561Not ApplicableNot Yet Recruiting

Efficacy and Safety Research of Cold Snare Polypectomy and Hot Snare Polypectomy in the Treatment of 4-9 mm Diameter Colorectal 0-Isp and 0-Ip Polyps: a Prospective, Multicenter, Randomized Controlled Study(FAST -REST Study)

Role: collaborator

NCT06534489Recruiting

Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment

Role: collaborator

NCT06515977Not ApplicableNot Yet Recruiting

Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions

Role: collaborator

NCT06390982Phase 2Not Yet Recruiting

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Role: collaborator

NCT06152640Not ApplicableRecruiting

A New Neuroregulatory Technology for the Therapy of AN Based on the Pathological Neural Network of ACC

Role: collaborator